quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:24:11·35d
ANALYSTRating
Tandem Diabetes Care Inc. logo

Tandem Diabetes Care upgraded by Truist with a new price target

TNDM· Tandem Diabetes Care Inc.
Health Care
Original source

Companies

  • TNDM
    Tandem Diabetes Care Inc.
    Health Care

Recent analyst ratings

  • Mar 19UpdateTruist$35.00
  • Mar 17UpdatePiper Sandler$33.00
  • Feb 23UpdateLake Street$50.00
  • Feb 20UpdateBofA Securities$30.00
  • Jan 27UpdateTD Cowen$25.00
  • Dec 16UpdateRobert W. Baird$30.00

Related

  • INSIDER6d
    SEC Form 4 filed by Kyrillos Jean-Claude
  • SEC16d
    SEC Form DEF 14A filed by Tandem Diabetes Care Inc.
  • SEC16d
    SEC Form DEFA14A filed by Tandem Diabetes Care Inc.
  • PR21d
    Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
  • SEC27d
    SEC Form PRE 14A filed by Tandem Diabetes Care Inc.
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Tandem Diabetes Care Inc.
  • INSIDER36d
    SEC Form 4 filed by Novara Mark David
  • ANALYST37d
    Tandem Diabetes Care upgraded by Piper Sandler with a new price target
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022